Headless WordPress - PROD

Shifting pathogen profiles and emerging agents are reshaping empiric treatment decisions for uncomplicated urinary tract infections

https://sharecareprofessional.top/hcp/urology/rethinking-first-line-uti-therapy

Resistance, renewal, and rethinking first-line UTI therapy

Novel mechanisms of action offer mechanistic differentiation from legacy agents as resistance pressures mount

https://sharecareprofessional.top/hcp/urology/dual-target-uuti-antibacterials

Decoding the dual-target advantage in emerging uUTI antibacterials

Balancing therapeutic innovation and resistance preservation requires deliberate integration of new uUTI options

https://sharecareprofessional.top/hcp/urology/novel-agents-antimicrobial-stewardship

Positioning novel agents within antimicrobial stewardship frameworks

Updated guideline recognition of nonantibiotic approaches is reshaping long-term management for recurrence-prone patients

https://sharecareprofessional.top/hcp/urology/recurrent-uuti-prevention-strategies

Beyond antibiotics: evolving strategies in recurrent uUTI prevention

Featured Content

Dx Dialogues: Uncomplicated urinary tract infections

Board-certified urologist and professor of urology Anne Pelletier Cameron, MD FRCSC URPS, explores the evolving landscape of UTI care, covering new therapeutic approaches, what's on the horizon for patient management, and the potential role of artificial intelligence in identifying infection-causing organisms earlier than ever before.

|Decoding the dual-target advantage in emerging uUTI antibacterials|Positioning novel agents within antimicrobial stewardship frameworks|Beyond antibiotics: evolving strategies in recurrent uUTI prevention|Resistance